expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology Today
qolumnistRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)TRT WorldVečer
العين الإخبارية 
Toi StaffAgenciesEmanuel FabianJacob MagidLazar BermanReutersLuke TressZev Stub
Gideon LevyJeffrey SachsPeter BaumThe Japan News EditorialJessica SteinbergGrace GilsonNurit YohananRossella TercatinStav LevatonNava FreibergJeremy SharonEman Abu ZayedSam SokolAhmad IbsaisAsaf Elia-ShalevSam Goldstein Ph.dMojca Furlan - RusNour Elassy
Jason Hickel
Yossi Klein HaleviJasim Al-Azzawi
Belen FernandezDavid HorovitzDiana BletterCharlie SummersPhilissa Cramer
Rachel MarsdenE-International Relations
Mikhail Salita
Ezzideen Shehab
Andrew Silow-CarrollIris LealThe Asahi ShimbunAmanda Borschel-Dan
Robert Sarner
Constantin Von HoffmeisterRobert PhilpotAzmat AliRobyne Hanley-Dafoe Ed.dMichael Bachner
Tarik Cyril AmarAvigail Sperber
|
 |
This story is part of Forbes’ coverage of India’s Richest 2025. See the full list here.
Speculation about succession at Sun Pharmaceutical Industries, India’s most valuable drug maker, was put to rest this year when its billionaire founder, © Forbes
visit website 
login
who are we?
contact us
qosheapp
